» Articles » PMID: 23998480

Tackling the Physiological Barriers for Successful Mesenchymal Stem Cell Transplantation into the Central Nervous System

Overview
Publisher Biomed Central
Date 2013 Sep 4
PMID 23998480
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past decade a lot of research has been performed towards the therapeutic use of mesenchymal stem cells (MSCs) in neurodegenerative and neuroinflammatory diseases. MSCs have shown to be beneficial in different preclinical studies of central nervous system (CNS) disorders due to their immunomodulatory properties and their capacity to secrete various growth factors. Nevertheless, most of the transplanted cells die within the first hours after transplantation and induce a neuroinflammatory response. In order to increase the efficacy of MSC transplantation, it is thus imperative to completely characterise the mechanisms mediating neuroinflammation and cell death following MSC transplantation into the CNS. Consequently, different components of these cell death- and neuroinflammation-inducing pathways can be targeted in an attempt to improve the therapeutic potential of MSCs for CNS disorders.

Citing Articles

Hua-Feng-Dan Alleviates LPS-induced Neuroinflammation by Inhibiting the TLR4/Myd88/NF-κB Pathway: Integrating Network Pharmacology and Experimental Validation.

Zhang Z, Pei Y, Zheng Y, Liu Y, Guo Y, He Y Curr Pharm Des. 2024; 30(28):2229-2243.

PMID: 38910274 DOI: 10.2174/0113816128300103240529114808.


Intracerebellar injection of monocytic immature myeloid cells prevents the adverse effects caused by stereotactic surgery in a model of cerebellar neurodegeneration.

Del Pilar C, Garrido-Matilla L, Del Pozo-Filiu L, Lebron-Galan R, Arias R, Clemente D J Neuroinflammation. 2024; 21(1):49.

PMID: 38355633 PMC: 10867997. DOI: 10.1186/s12974-023-03000-8.


Promising Strategies for the Development of Advanced In Vitro Models with High Predictive Power in Ischaemic Stroke Research.

Van Breedam E, Ponsaerts P Int J Mol Sci. 2022; 23(13).

PMID: 35806146 PMC: 9266337. DOI: 10.3390/ijms23137140.


Optimized Longitudinal Monitoring of Stem Cell Grafts in Mouse Brain Using a Novel Bioluminescent/Near Infrared Fluorescent Fusion Reporter.

Mezzanotte L, Iljas J, Que I, Chan A, Kaijzel E, Hoeben R Cell Transplant. 2018; 26(12):1878-1889.

PMID: 29390874 PMC: 5802635. DOI: 10.1177/0963689717739718.


Concise Review: Innate and Adaptive Immune Recognition of Allogeneic and Xenogeneic Cell Transplants in the Central Nervous System.

Hoornaert C, Le Blon D, Quarta A, Daans J, Goossens H, Berneman Z Stem Cells Transl Med. 2017; 6(5):1434-1441.

PMID: 28244236 PMC: 5442707. DOI: 10.1002/sctm.16-0434.


References
1.
Denes A, Ferenczi S, Halasz J, Kornyei Z, Kovacs K . Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab. 2008; 28(10):1707-21. DOI: 10.1038/jcbfm.2008.64. View

2.
Cao W, Guo X, Chen K, Xu R, Zheng H, Wang J . Inhibition of hypoxia and serum deprivation-induced apoptosis by salvianolic acid in rat mesenchymal stem cells. J Tradit Chin Med. 2012; 32(2):222-8. DOI: 10.1016/s0254-6272(13)60015-1. View

3.
Hong S, Zhang H, You J, Zhang M, Cai Y, Jiang X . Comparison of transdifferentiated and untransdifferentiated human umbilical mesenchymal stem cells in rats after traumatic brain injury. Neurochem Res. 2011; 36(12):2391-400. DOI: 10.1007/s11064-011-0567-2. View

4.
Zanier E, Montinaro M, Vigano M, Villa P, Fumagalli S, Pischiutta F . Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med. 2011; 39(11):2501-10. DOI: 10.1097/CCM.0b013e31822629ba. View

5.
Hanke M, Kielian T . Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond). 2011; 121(9):367-87. PMC: 4231819. DOI: 10.1042/CS20110164. View